title: IkappaB kinase beta phosphorylates the K63 deubiquitinase A20 to cause feedback inhibition of the NF-kappaB pathway.
abstract: Misregulation of NF-kappaB signaling leads to infectious, inflammatory, or autoimmune disorders. IkappaB kinase beta (IKKbeta) is an essential activator of NF-kappaB and is known to phosphorylate the NF-kappaB inhibitor, IkappaBalpha, allowing it to undergo ubiquitin-mediated proteasomal degradation. However, beyond IkappaBalpha, few additional IKKbeta substrates have been identified. Here we utilize a peptide library and bioinformatic approach to predict likely substrates of IKKbeta. This approach predicted Ser381 of the K63 deubiquitinase A20 as a likely site of IKKbeta phosphorylation. While A20 is a known negative regulator of innate immune signaling pathways, the mechanisms regulating the activity of A20 are poorly understood. We show that IKKbeta phosphorylates A20 in vitro and in vivo at serine 381, and we further show that this phosphorylation event increases the ability of A20 to inhibit the NF-kappaB signaling pathway. Phosphorylation of A20 by IKKbeta thus represents part of a novel feedback loop that regulates the duration of NF-kappaB signaling following activation of innate immune signaling pathways.
authors: Department of Systems Biology, Harvard Medical School, Boston, Massachusetts, USA.
authors: Jessica E
authors: JE
authors: Hutti
authors: Benjamin E
authors: BE
authors: Turk
authors: John M
authors: JM
authors: Asara
authors: Averil
authors: A
authors: Ma
authors: Lewis C
authors: LC
authors: Cantley
authors: Derek W
authors: DW
authors: Abbott
mesh_terms: D000465:Algorithms; D020816:Amino Acid Motifs; D000595:Amino Acid Sequence; D000818:Animals; D045163:Antibodies, Phospho-Specific / Q000494:pharmacology; D002460:Cell Line; D003546:Cysteine Endopeptidases; D025461:Feedback, Physiological; D006801:Humans; D051550:I-kappa B Kinase / Q000737:chemistry / Q000378:metabolism*; D047908:Intracellular Signaling Peptides and Proteins / Q000378:metabolism*; D008070:Lipopolysaccharides / Q000494:pharmacology; D051379:Mice; D008954:Models, Biological; D008969:Molecular Sequence Data; D016328:NF-kappa B / Q000037:antagonists & inhibitors / Q000378:metabolism*; D009687:Nuclear Proteins / Q000378:metabolism*; D010766:Phosphorylation / Q000187:drug effects; D012694:Serine / Q000378:metabolism; D013379:Substrate Specificity / Q000187:drug effects; D013997:Time Factors; D000072598:Tumor Necrosis Factor alpha-Induced Protein 3
chemical_list: D045163:Antibodies, Phospho-Specific; D047908:Intracellular Signaling Peptides and Proteins; D008070:Lipopolysaccharides; D016328:NF-kappa B; D009687:Nuclear Proteins; D012694:Serine; D051550:I-kappa B Kinase; D000072598:Tumor Necrosis Factor alpha-Induced Protein 3; D003546:Cysteine Endopeptidases; C513261:Tnfaip3 protein, mouse
references: Proc Natl Acad Sci U S A. 1996 Jun 25;93(13):6721-5
references: 8692885
references: J Mol Biol. 1999 Dec 17;294(5):1351-62
references: 10600390
references: Immunity. 2000 Mar;12(3):301-11
references: 10755617
references: Science. 2000 Sep 29;289(5488):2350-4
references: 11009421
references: Cell. 2000 Oct 13;103(2):351-61
references: 11057907
references: Nat Biotechnol. 2001 Apr;19(4):348-53
references: 11283593
references: J Biol Chem. 2002 Jul 5;277(27):24331-9
references: 11971901
references: J Biol Chem. 2002 Dec 13;277(50):48115-21
references: 12351658
references: Nucleic Acids Res. 2003 Jul 1;31(13):3635-41
references: 12824383
references: Semin Immunol. 2004 Feb;16(1):3-9
references: 14751757
references: Biochem J. 2004 Mar 15;378(Pt 3):727-34
references: 14748687
references: Cell. 2004 Apr 16;117(2):225-37
references: 15084260
references: Nature. 2004 Aug 5;430(7000):694-9
references: 15258597
references: Genes Dev. 2004 Sep 15;18(18):2195-224
references: 15371334
references: Nat Immunol. 2004 Oct;5(10):1052-60
references: 15334086
references: J Biol Chem. 1990 Sep 5;265(25):14705-8
references: 2118515
references: J Biol Chem. 1992 Sep 5;267(25):17971-6
references: 1381359
references: Nature. 1997 Aug 7;388(6642):548-54
references: 9252186
references: Science. 1997 Oct 31;278(5339):860-6
references: 9346484
references: FEBS Lett. 1999 Jan 15;442(2-3):147-50
references: 9928991
references: J Biol Chem. 1999 Oct 22;274(43):30353-6
references: 10521409
references: Proc Natl Acad Sci U S A. 2004 Dec 14;101(50):17416-21
references: 15574499
references: Curr Biol. 2004 Dec 29;14(24):2217-27
references: 15620648
references: Nat Methods. 2004 Oct;1(1):27-9
references: 15782149
references: EMBO Rep. 2005 Apr;6(4):321-6
references: 15809659
references: Nat Cell Biol. 2005 Aug;7(8):758-65
references: 16056267
references: Science. 2005 Sep 16;309(5742):1857-61
references: 16166517
references: Nat Rev Immunol. 2005 Oct;5(10):749-59
references: 16175180
references: Nat Rev Immunol. 2006 Jan;6(1):9-20
references: 16493424
references: Mol Cell. 2006 Jun 9;22(5):561-9
references: 16762830
references: Mol Cell. 2006 Jul 7;23(1):13-23
references: 16818229
references: Oncogene. 2006 Oct 30;25(51):6685-705
references: 17072322
references: Oncogene. 2006 Oct 30;25(51):6717-30
references: 17072324
references: Oncogene. 2006 Oct 30;25(51):6817-30
references: 17072330
references: Nat Rev Mol Cell Biol. 2007 Jan;8(1):49-62
references: 17183360
references: Nat Protoc. 2006;1(1):375-9
references: 17406259
references: Mol Cell Biol. 2007 Sep;27(17):6012-25
references: 17562858